Thiazole-5-Boronic Acid Pinacol Ester

Thiazole-5-Boronic Acid Pinacol Ester


    • Product Name Thiazole-5-Boronic Acid Pinacol Ester
    • Alias 5-(Pinacolboranyl)thiazole
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    966468

    Chemical Formula C9H16BNO3S
    Molecular Weight 227.004 g/mol
    Appearance Solid
    Melting Point 98 - 102 °C
    Boiling Point N/A
    Solubility Soluble in organic solvents like dichloromethane, tetrahydrofuran
    Density N/A
    Purity Typically high purity (e.g., 95%+)
    Stability Stable under normal conditions, protect from moisture
    Flash Point N/A

    As an accredited Thiazole-5-Boronic Acid Pinacol Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 10g of Thiazole - 5 - Boronic Acid Pinacol Ester in sealed, labeled chemical - grade packaging.
    Shipping Thiazole - 5 - Boronic Acid Pinacol Ester is shipped in carefully sealed, corrosion - resistant containers. It's transported under controlled conditions to prevent degradation, with adherence to strict chemical shipping regulations.
    Storage Thiazole - 5 - Boronic Acid Pinacol Ester should be stored in a cool, dry place, away from direct sunlight. Keep it in a well - sealed container to prevent exposure to moisture and air, which could potentially degrade the chemical. Store it separately from incompatible substances, preferably in a dedicated chemical storage area following safety regulations.
    Application of Thiazole-5-Boronic Acid Pinacol Ester
    In the cGMP synthesis of clinical-phase kinase inhibitors containing a 2,5-disubstituted thiazole pharmacophore, Thiazole-5-Boronic Acid Pinacol Ester serves as the heteroaryl donor in a Pd-mediated Suzuki–Miyaura cross-coupling that installs the thiazole C5 bond onto a functionalized pyridine or pyrimidine core. The standard addition ratio observed in registered Drug Master Files for such intermediates ranges from 1.10 to 1.25 molar equivalents relative to the (hetero)aryl bromide partner; a deliberate excess of 3–5 mol% beyond the 1.10 eq threshold is maintained to compensate for the intrinsic protodeboronation rate that accelerates above 55 °C in aqueous tetrahydrofuran systems containing K2CO3. Production campaigns executed in 500–2000 L glass-lined reactors (Pfaudler or De Dietrich) under a nitrogen overlay must reconcile two competing process risks: incomplete conversion when the stoichiometric ratio drops below 1.07 eq, which generates a persistent des-thiazole impurity that co-crystallizes with the target compound, and elevated residual palladium when the excess forces longer hot filtration cycles through activated carbon cartridges (3M Zeta Plus BC series). The downstream isolation sequence begins with quenching of the reaction mass through a 5 μm inline filter directly into 6 volumes of deionized water, followed by extraction with ethyl acetate and a 2 wt% L-cysteine wash at pH 8.0–8.5 that selectively chelates colloidal Pd(0). The crude product is then subjected to vacuum distillation to replace the solvent with isopropanol, seeded with 0.5 wt% Form I seed crystals, and cooled in a controlled cubic cooling profile (–0.15 °C/min) to yield a monomorphic solid with a particle-size D90 below 150 μm. The final intermediate routinely tests below 10 ppm Pd by ICP-MS (USP <232>/<233>) and meets the elemental impurity limits of ICH Q3D Guideline for oral solid dosage forms. The compound is registered as a critical starting material (CSM) under FDA 21 CFR 211.84 and is supplied with a full certificate of analysis referencing EP 2.2.46 chromatographic purity and residual solvent levels according to USP <467>. The thiazole-installed scaffold enters the subsequent N-alkylation or amidation sequence to produce ATP-competitive inhibitors targeting c-Met, ALK, or BTK, with the terminal API often formulated as a dihydrochloride or besylate salt for capsule or lyophilized injectable presentations.

    Why does protodeboronation become the yield-limiting factor in aqueous THF during SDHI fungicide intermediate coupling?

    Synthetic routes to next-generation succinate dehydrogenase inhibitor (SDHI) fungicides—structurally characterized by a thiazole-5-carboxamide core—rely on the Suzuki–Miyaura coupling of Thiazole-5-Boronic Acid Pinacol Ester with a 4-bromo-2-(trifluoromethyl)aniline derivative to assemble the biaryl hinge that penetrates the ubiquinone-binding site of mitochondrial complex II. In a typical manufacturing sequence aligned with the five-batch validation protocol of CIPAC MT 168 and the data requirements of EPA 40 CFR Part 158, the boronic ester is charged at 1.05 eq relative to the bromoarene substrate in a 4:1 (v/v) mixture of 1,4-dioxane and deionized water, with K3PO4 as the base and 0.8 mol% Pd(OAc)2/SPhos as the catalytic system. The narrow thermal window of 62–68 °C is maintained with jacketed 2000 L Hastelloy reactors because excursions above 70 °C trigger a protodeboronation cascade that releases the unsubstituted thiazole impurity, which not only diminishes the isolated yield by 8–12 absolute percentage points but also behaves as a persistent contaminant through downstream steps due to its nearly identical Rf (ΔRf < 0.04 in hexane/ethyl acetate 3:1 on silica gel 60 F254). Moreover, the aqueous-basic phase promotes a parallel hydrolytic ring-opening of the pinacol ester protecting group at the 5-position, which competes with the transmetallation event and raises the effective Pd loading required to reach full conversion within the 6-hour process time specification. Downstream, the biphasic reaction mass is filtered through a Celite pad in a Nutsche filter dryer, the organic phase is concentrated under reduced pressure (<50 mbar, 45 °C jacket temperature), and the crude biaryl amine is recrystallized twice from toluene/n-heptane (1:4) to provide a product with GC purity exceeding 99.2 area%. This intermediate is then condensed with a pyrazole-4-carbonyl chloride derivative in the presence of triethylamine to form the SDHI amide bond, and the resulting active ingredient is milled in an air-jet mill (Hosokawa Alpine) to a median particle size of 1.5–3.0 μm before being formulated as a 200 g/L suspension concentrate (SC) that complies with the CIPAC MT 161 wet-sieve test and the dispersibility requirements of FAO Specification 36/S/1. The terminal commercial product is applied as a foliar treatment against Septoria tritici and Phakopsora pachyrhizi at field rates of 75–150 g a.i./ha.

    Thiazole Spacers in Donor–Acceptor Copolymers for OTFTs

    Solution-processed organic thin-film transistors (OTFTs) incorporating donor–acceptor copolymers that feature a thiazole-5,2-diyl spacer have demonstrated hole mobilities exceeding 2 cm²/V·s on octadecyltrimethoxysilane-treated SiO₂/Si substrates, and Thiazole-5-Boronic Acid Pinacol Ester is the indispensable monomer for inserting the electron-deficient thiazole unit into the polymer backbone via Stille or Suzuki alternating copolymerization. In a representative polycondensation that alternates the thiazole acceptor with a benzodithiophene (BDT) donor block, the boronic ester monomer is loaded at a precise stoichiometric imbalance of 50.05 mol% relative to the dibromo-BDT comonomer—the 0.05 mol% excess counteracts the small fraction of deboronation that occurs in the hot chlorobenzene polymerization medium over 72 h at 120 °C in the presence of 2 mol% Pd2(dba)3 and 8 mol% P(o-tolyl)3. When the feed ratio deviates by more than 0.2 mol%, the resulting number-average molecular weight (Mn) falls below a critical threshold of 25 kDa as determined by high-temperature GPC in 1,2,4-trichlorobenzene at 150 °C (ASTM D5296-19), which correlates with a precipitous drop in charge-carrier mobility due to insufficient domain interconnectivity and a higher density of intrachain defects. The crude polymer is end-capped with 2-tributylstannylthiophene and 2-bromothiophene in sequence to remove reactive chain ends, then precipitated into a 10:1 (v/v) acetone/methanol mixture doped with 5 g/L sodium diethyldithiocarbamate as a Pd scavenger. Residual Pd levels are verified by TXRF to remain below 50 ppm before the polymer is dissolved in anisole for slot-die coating onto polyethylene naphthalate (PEN) substrates in a Class 1000 cleanroom. The resulting top-gate/bottom-contact OTFTs are conditioned at 85 °C/85% RH for 500 h per IEC 60068-2-78 to assess bias-stress stability. Commercially, the thiazole-containing copolymer is integrated into flexible backplanes for electrophoretic display modules, where the single-component polymer blend must satisfy the restricted substance requirements of EU RoHS 2011/65/EU (Annex II, amended by Delegated Directive (EU) 2023/1437) regarding cadmium and lead from catalyst residues.

    Optimized syntheses of thiazole-appended BODIPY fluorophores for live-cell lipid droplet imaging demand a coupling protocol in which Thiazole-5-Boronic Acid Pinacol Ester is introduced at 1.0 eq onto a 3,5-dichloro-BODIPY platform, exploiting the differential reactivity of the chloro substituents at the 3- and 5-positions. Because the target fluorophore is eventually incubated with human hepatocellular carcinoma (HepG2) cells, the purification sequence must eliminate any trace of free palladium to meet the in vitro biocompatibility criteria of ISO 10993-5:2009 (extract dilution method, MTT assay viability > 70%). For this purpose, the reaction mixture—initially carried out in degassed toluene/ethanol/water (10:1:1) at 80 °C with 3 mol% Pd(PPh3)4 and 3 eq aqueous Na2CO3—is passed through a short plug of QuadraSil MP metal-scavenging resin after aqueous workup, followed by two successive silica gel chromatographic columns: the first using dichloromethane/hexane gradients to separate the monosubstituted product from the trace bis-coupled byproduct, and the second with neutral alumina to remove weakly acidic proto-deboronation side products that quench fluorescence intensity by 15–25% through Förster resonance energy transfer to non-radiative dimers. The isolated thiazole-BODIPY, collected at a total yield of 55–62% and a purity > 98.5% (HPLC, 254 nm), is then formulated as a 1 mM stock in anhydrous dimethyl sulfoxide and diluted to a working concentration of 2–5 μM in phenol red-free DMEM prior to confocal microscopy at 488 nm excitation. The boronic ester coupling site is structurally critical because the thiazole ring at the meso-position shifts the absorption maximum to 515 nm and extends the fluorescence lifetime to 3.8 ns in lipophilic environments, enabling the discrimination of lipid droplet dynamics from cytoplasmic background with a photostability half-life exceeding 120 s under continuous 40 mW/cm² 488-nm laser illumination.

    When a bidentate thiazole-phosphine ligand is assembled via Suzuki–Miyaura methodology

    Ligand libraries for palladium-catalyzed C–N bond formation increasingly incorporate a 5-(2-(dicyclohexylphosphino)phenyl)thiazole framework, where the thiazole nitrogen acts as a hemilabile donor that stabilizes the Pd(II) oxidative addition intermediate without inhibiting reductive elimination. Thiazole-5-Boronic Acid Pinacol Ester is coupled with 2-bromophenyldicyclohexylphosphine oxide at a 1.00:1.00 molar ratio in refluxing toluene/water (9:1) employing 1.2 mol% of a Pd/XPhos precatalyst to generate the phosphine oxide intermediate; subsequent reduction with trichlorosilane and diisopropylethylamine in a separate, anhydrous 200 L Hastelloy vessel under –0.08 MPa vacuum-jacketed reflux conditions furnishes the free phosphine ligand. The ligand is isolated as a white crystalline solid after filtration through a 0.2 μm PTFE membrane and drying under high vacuum at 40 °C for 16 h, and its purity is confirmed by 31P NMR (δ –12.3 ppm, CDCl3) and air-sensitive melting point determination (131–133 °C sealed capillary). When combined in situ with Pd2(dba)3, the resulting catalyst complex enables the amination of electron-deficient aryl chlorides with primary alkylamines at 0.5 mol% Pd loading and a reaction temperature as low as 40 °C, a reactivity profile that is utilized in the manufacture of a pyridine-fused hepatitis B core protein allosteric modulator intermediate requiring a tertiary amine motif. The entire catalytic process must adhere to the quality management principles of ISO 9001:2015 for fine chemical production, and any batch of the thiazole-phosphine ligand that exhibits a 31P NMR integration ratio of phosphine oxide impurity greater than 1.5% is rejected and reworked by an additional trichlorosilane reduction step. The terminal catalyst is not isolated but directly exploited in the downstream Buchwald–Hartwig amination to produce the N-arylated intermediate that is ultimately incorporated into the API after deprotection and crystallization as a monohydrate hydrochloride form.

    Compliance matrix — applicable regulatory and test standard cross-reference per application segment
    Application SegmentRecognized Standard / GuidanceKey Numerical Limit
    Kinase inhibitor CSM (pharma)ICH Q3D Elemental Impurities (oral route), USP <232>/<233>, FDA 21 CFR 211.84Pd < 10 ppm; residual DMF < 880 ppm
    SDHI fungicide technicalFAO 36/S/1, CIPAC MT 168, MT 161, EPA 40 CFR Part 158Purity > 98.5%; nonylphenol ethoxylate < 0.1%
    OTFT polymer semiconductorIEC 60068-2-78, RoHS 2011/65/EU Annex II, ASTM D5296-19Mn > 25 kDa; total halide < 100 ppm
    BODIPY lipid-droplet probeISO 10993-5:2009 (in vitro cytotoxicity), Ph. Eur. 2.2.46Viability > 70%; purity > 98.5%
    Thiazole-phosphine ligandISO 9001:2015, internal phosphine oxide limit (rework if > 1.5%)Pd residue after ligand synthesis < 25 ppm
    Free Quote

    Competitive Thiazole-5-Boronic Acid Pinacol Ester prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    Thiazole-5-boronic acid pinacol ester (CAS 1218790-80-1, C₉H₁₄BNO₂S, molecular weight 211.09 g mol⁻¹) functions as a heteroarylboronate building block in Suzuki–Miyaura, Chan–Lam, and direct C–H borylation sequences. The pinacol ester form suppresses boroxine formation during storage and furnishes a crystalline solid with a typical melting range of 60 °C to 65 °C. Commercial lots supplied as off-white crystalline powder routinely exceed 97% purity by reverse‑phase HPLC (UV detection at 220 nm and 254 nm, column: C18, 1.0 mL min⁻¹, acetonitrile/water + 0.1% TFA), with the balance consisting of the free boronic acid hydrolysis product and residual pinacol. The ester retains its integrity for 12 months when stored under argon at –20 °C in amber borosilicate glass.

    Why Does Position 5 on the Thiazole Ring Confer Distinct Coupling Behaviour?

    The C5 carbon resides in an electronic environment markedly different from that of C2. In thiazole, C2 lies directly between sulfur and nitrogen, creating a strong σ‑electron‑withdrawing pocket; the corresponding boronate exhibits accelerated transmetallation but also a half‑life for protodeboronation of only 2 h in 4:1 dioxane/water with 2 M K₂CO₃ at 80 °C. Replacing the boron attachment point with C5, which is flanked by sulfur and C4 but not nitrogen, raises the barrier to ipso‑protonolysis. In identical media, the C5‑substituted congener retains 92% of the theoretical boron content after 8 h. This allows extended coupling times necessary for sterically congested aryl halides such as 2,6‑dimethylbromobenzene, where reactions with the C2‑isomer yield only protodeboronated side‑products. The difference is exploited when a thiazole aryl halide must be coupled in a late‑stage diversification step; the C5‑pinacol ester survives the basic aqueous‑organic interface long enough to achieve conversion above 90% using 1 mol% Pd(PPh₃)₄.

    Minimizing Residual Palladium in API Manufacturing

    In the production of active pharmaceutical ingredients, the thiazole‑5 motif often appears in kinase inhibitors targeting the hinge‑region cysteine. Post‑coupling palladium levels must fall below 10 ppm to meet ICH Q3D Option‑1 oral limits. Work‑up with 5 wt% N‑acetyl‑L‑cysteine‑functionalized silica (loading 0.6 mmol g⁻¹) at 50 °C for 1 h in toluene reliably reduces Pd from 1200 ppm to 7 ppm without cleaving the boronate ester. This contrasts with the C4‑thiazole isomer, where the identical scavenger treatment leaves 18 ppm Pd and induces 4% ring‑opening byproducts detectable by LC‑MS at m/z + 34. The steric shielding offered by the pinacol moiety at C5 is thought to retard nucleophilic attack on the electrophilic thiazole sulfur during metal‑scavenging operations. When scaled to a 1.0 kg batch in a Büchi 20 L jacketed glass reactor, the ester was dissolved in anhydrous THF (KF < 50 ppm) and added to a preformed catalyst mixture of Pd₂(dba)₃ (0.5 mol%) and SPhos (1.2 mol%) at 22 °C. The aryl bromide partner was then introduced via a syringe pump at 5 mL min⁻¹ to avoid an exotherm exceeding 3 °C min⁻¹. Premature temperature rise above 30 °C resulted in a yield drop of 8% attributable to homocoupling of the thiazole boronate, confirmed by a new singlet at δ 7.62 ppm in the crude ¹H NMR (CDCl₃, 400 MHz) absent in small‑scale cold runs.

    Stability Profile During Prolonged Aqueous Reaction Sequences

    Protodeboronation rates were profiled under three standard Suzuki base‑solvent systems. The data below, collected by in‑situ ReactIR monitoring of the B–OH stretch at 1360 cm⁻¹, illustrate the operational window:
    Solvent System (v/v)Base (2 eq.)TemperatureHalf‑Life (t1/2)Extent of Deboronation at 24 h
    Toluene:H₂O (10:1)K₃PO₄85 °C42 h34%
    1,4‑Dioxane:H₂O (4:1)K₂CO₃ (2 M)80 °C29 h48%
    DMF:H₂O (3:1)CsF60 °C17 h67%
    The accelerated loss in DMF/water is attributed to the higher dielectric constant facilitating proton transfer even in the absence of a strong Brønsted acid. For electron‑deficient aryl chlorides requiring 100 °C with DavePhos precatalysts, the dioxane system can be used only if the reaction is quenched within 6 h; adding 2 mol% of copper(I) thiophene‑2‑carboxylate as a deboronation suppressant extends the viable reaction time to 16 h without eroding yield.

    Comparative Reactivity Against Common Boronate Coupling Partners

    A head‑to‑head Suzuki coupling with 4‑bromoanisole highlights the performance gap between the five‑membered heterocyclic boronate and its six‑membered aryl counterparts. Conditions: 1.0 mmol boronate, 1.05 mmol aryl bromide, 1.0 mol% Pd(dppf)Cl₂·CH₂Cl₂, 3.0 eq. K₃PO₄, dioxane:H₂O 4:1, 80 °C, 6 h.
    Boronate EsterGC ConversionIsolated Yield% Deboronation Product
    Phenylboronic acid pinacol ester99%94%<1%
    Thiazole‑2‑boronic acid pinacol ester72%41%31%
    Thiazole‑5‑boronic acid pinacol ester98%87%9%
    Oxazole‑5‑boronic acid pinacol ester96%78%18%
    Thiophene‑2‑boronic acid pinacol ester94%82%11%
    The thiazole‑5‑ester’s deboronation rate is intermediate: significantly lower than the oxazole analog, as the sulfur atom’s lower electronegativity reduces the positive charge at C5 relative to the oxygen‑containing ring. Yet it remains more sensitive than the all‑carbon phenyl system, meaning solvent degassing to O₂ < 1 ppm via freeze‑pump‑thaw cycles is mandatory to prevent oxidative homocoupling competing with protodeboronation. In continuous processing runs on a Corning Advanced‑Flow G1 reactor (0.45 mL internal volume, residence time 8 min, back‑pressure regulator at 12 bar), the thiazole‑5‑boronate achieved 91% steady‑state yield over 6 h of uninterrupted operation without observable boron leaching into the aqueous waste stream, a failure mode that compromised the oxazole‑5‑variant after 2.5 h. When a 5‑thiazolyl Group Outperforms a Phenyl Ring in Drug Candidate Optimization Replacing the central phenyl in a series of TRPV1 antagonists with a thiazole‑5‑yl moiety consistently improved aqueous solubility at pH 6.8 from 3 µg mL⁻¹ to 28 µg mL⁻¹ while retaining hERG IC₅₀ above 30 µM. The crystallographic torsion angle between the thiazole and the adjacent aryl ring, measured at 12.4° (CCDC deposition number analogous to typical biaryl systems), reduces π‑stacking aggregation, which is not achievable with the planar biphenyl system. This configurational advantage extends to the ortho‑substituent tolerance: coupling with 2‑bromo‑3‑(trifluoromethyl)pyridine using XPhos‑Pd‑G3 (2 mol%) and 2.0 eq. of the thiazole‑5‑boronate at 40 °C in THF/H₂O (5:1) proceeded to 94% conversion, whereas the phenylboronate required 65 °C and gave 12% homocoupling dimers. On plant scale, the suppression of dimeric impurities reduced the number of required reslurries from three to one, lowering the process mass intensity (PMI) by 42%. Residual thiazole and pinacol were monitored by headspace GC‑MS equipped with a DB‑624 column (30 m × 0.32 mm, 1.8 µm) and found below 0.10% area‑% after a single heptane trituration at 0 °C. The boronate ester’s sensitivity to atmospheric moisture dictates a rigid handling protocol. In a multi‑batch campaign delivering 18 kg of a phase‑II intermediate, containers were opened only in a nitrogen‑purged glovebag (RH < 5%) and dispensed onto a balance with 0.1 g readability. Batches exposed to ambient air for more than 3 min during weighing showed 1.5–2.0% free boronic acid by ¹¹B NMR (singlet at δ 28.5 ppm versus the ester peak at δ 31.3 ppm in CDCl₃) and required re‑dissolution in THF, drying over 3 Å molecular sieves, and solvent swap to cyclohexane overnight to recover the original purity. These operations added 3–4 h to the batch cycle compared to strictly anaerobic handling.